Dydrogesterona [INN-Spanish] en es it fr

Dydrogesterona [INN-Spanish] Brand names, Dydrogesterona [INN-Spanish] Analogs

Dydrogesterona [INN-Spanish] Brand Names Mixture

  • No information avaliable

Dydrogesterona [INN-Spanish] Chemical_Formula


Dydrogesterona [INN-Spanish] RX_link


Dydrogesterona [INN-Spanish] fda sheet

Dydrogesterona_[INN-Spanish] FDA

Dydrogesterona [INN-Spanish] msds (material safety sheet)

Dydrogesterona [INN-Spanish] Synthesis Reference

No information avaliable

Dydrogesterona [INN-Spanish] Molecular Weight

302.415 g/mol

Dydrogesterona [INN-Spanish] Melting Point

No information avaliable

Dydrogesterona [INN-Spanish] H2O Solubility

Soluble (difumarate formulation)

Dydrogesterona [INN-Spanish] State


Dydrogesterona [INN-Spanish] LogP


Dydrogesterona [INN-Spanish] Dosage Forms

Opthalmic solution (0.05%)

Dydrogesterona [INN-Spanish] Indication

For the temporary relief of the signs and symptoms of allergic conjunctivitis.

Dydrogesterona [INN-Spanish] Pharmacology

Emedastine is a relatively selective H1-receptor antagonist.

Dydrogesterona [INN-Spanish] Absorption

Ophthalmic use of emedastine usually does not produce measurable plasma concentrations.

Dydrogesterona [INN-Spanish] side effects and Toxicity

Somnolence and malaise have been reported following daily oral administration.

Dydrogesterona [INN-Spanish] Patient Information

Dydrogesterona [INN-Spanish] Organisms Affected

Humans and other mammals